CANDRIAM S.C.A. – Biogen Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$67.06M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+30.92%
quarter
Biogen Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.41% | -1.03K shares | 15.63M | $267 | 251.15K |
Q2 2022 | share | Increase | +3.76% | 9.13K shares | 244K | $203.94 | 252.19K |
Q1 2022 | share | Increase | +11.56% | 25.18K shares | -1.08M | $210.6 | 243.06K |
Q4 2021 | share | Decrease | -20.09% | -54.76K shares | -24.87M | $240 | 217.87K |
Q3 2021 | share | Decrease | -0.87% | -2.39K shares | -18.08M | $282.99 | 272.64K |
Q2 2021 | share | Decrease | -29.63% | -115.83K shares | 3.30M | $346.27 | 275.04K |
Q1 2021 | share | 0.00% | 0 shares | -3.77M | $279.75 | 390.87K | |
Q4 2020 | share | Increase | +6.33% | 23.28K shares | -8.56M | $244.86 | 390.87K |
Q3 2020 | share | Increase | +7.82% | 26.67K shares | 13.05M | $283.68 | 367.58K |
Q2 2020 | share | Decrease | -13.53% | -53.34K shares | -23.14M | $267.55 | 340.91K |
Q1 2020 | share | 0.00% | 0 shares | -2.62M | $316.38 | 394.26K | |
Q4 2019 | share | Decrease | -10.11% | -44.32K shares | 14.87M | $296.73 | 394.26K |
Q3 2019 | share | Decrease | -29.79% | -186.13K shares | -43.35M | $232.82 | 438.58K |
Q2 2019 | share | Decrease | -4.55% | -29.77K shares | -9.25M | $233.87 | 624.72K |
Q1 2019 | share | Increase | +14.88% | 84.75K shares | -16.72M | $236.38 | 654.49K |
Q4 2018 | share | Increase | +12.17% | 61.80K shares | -8.02M | $300.92 | 569.74K |
Q3 2018 | share | Increase | +67.83% | 205.29K shares | 91.61M | $353.31 | 507.93K |
Q2 2018 | share | Increase | +47.52% | 97.48K shares | 31.66M | $290.24 | 302.64K |
Q1 2018 | share | Increase | +364.58% | 161K shares | 42.11M | $273.82 | 205.16K |
Q4 2017 | share | Decrease | -84.37% | -238.31K shares | -74.38M | $318.57 | 44.16K |
Q3 2017 | share | Increase | +28.63% | 62.87K shares | 28.85M | $313.12 | 282.47K |
Q2 2017 | share | Increase | +25.52% | 44.64K shares | 11.75M | $271.36 | 219.60K |
Q1 2017 | share | Decrease | -4.16% | -7.59K shares | -3.92M | $273.42 | 174.95K |
Q4 2016 | share | Decrease | -1.70% | -3.16K shares | -6.36M | $283.58 | 182.55K |
Q3 2016 | share | Increase | +11.97% | 19.85K shares | 18.02M | $313.03 | 185.71K |
Q2 2016 | share | Decrease | -8.57% | -15.53K shares | -6.85M | $241.82 | 165.86K |
Q1 2016 | share | Decrease | -25.36% | -61.61K shares | -27.48M | $260.32 | 181.4K |